Authors
Loading...
Randomized trial shows biological inertness of zirconium dioxide nanoparticles in targeted drug delivery, suggesting low toxicity.
Devasundar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: